Literature DB >> 23954615

Cytokine responses to quantiferon peptides in pediatric tuberculosis: a pilot study.

Marine Armand1, Vibol Chhor, Agathe de Lauzanne, Valérie Guérin-El Khourouj, Béatrice Pédron, Mohamed Jeljeli, Pierre Gressens, Albert Faye, Ghislaine Sterkers.   

Abstract

OBJECTIVES: Detailed understanding of tuberculosis (TB) immunopathology and cytokine/chemokine responses can ultimately lead to the development of new diagnostic tools, especially useful in children where TB diagnosis remains challenging.
METHODS: Nineteen cytokine/chemokine responses to Mycobacterium tuberculosis (M.tb) antigens were analyzed in 47 children distributed as follow: 28 with TB-disease (TD), 12 with latent TB and 7 uninfected controls. All the cytokines and chemokines were quantified in a multiplexed microsphere-based assay by using residual plasma from the quantiFERON kit (IFNγ release assay).
RESULTS: IP-10, IL-2, IL-5 and IL-13 were among the best cytokines to diagnose infection as related by the area under ROC curve for IP-10 (0.96, 95%CI: 0.91-1.00), IL-2 (0.98, 95%CI: 0.93-1.02), IL-5 (0.91, 95%CI: 0.81-1.01) and IL-13 (0.97, 95%CI: 0.93-1.00). None of the 5 biomarkers, however, discriminated TB-disease from latent-TB. Finally, lower IL-5 (p = 0.02) and IL-13 (p = 0.02) levels were observed in severe opposed to non-severe TB.
CONCLUSION: These results suggest that IP-10, IL-2, IL-5 and IL-13 may find a diagnostic application in pediatric tuberculosis and argue against the paradigm of a negative influence of Th2 responses in severe pediatric M.tb infection.
Copyright © 2013 The British Infection Association. Published by Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Children; Cytokines; IL-13; IL-2; IL-5; IP-10; Tuberculosis

Mesh:

Substances:

Year:  2013        PMID: 23954615     DOI: 10.1016/j.jinf.2013.08.005

Source DB:  PubMed          Journal:  J Infect        ISSN: 0163-4453            Impact factor:   6.072


  10 in total

1.  Potential Immunological Biomarkers for Detection of Mycobacterium tuberculosis Infection in a Setting Where M. tuberculosis Is Endemic, Ethiopia.

Authors:  Takele Teklu; Keehwan Kwon; Biniam Wondale; Milkessa HaileMariam; Aboma Zewude; Girmay Medhin; Mengistu Legesse; Rembert Pieper; Gobena Ameni
Journal:  Infect Immun       Date:  2018-03-22       Impact factor: 3.441

2.  Novel T-cell assays for the discrimination of active and latent tuberculosis infection: the diagnostic value of PPE family.

Authors:  Babak Pourakbari; Setareh Mamishi; Majid Marjani; Mehrnaz Rasulinejad; Sabrina Mariotti; Shima Mahmoudi
Journal:  Mol Diagn Ther       Date:  2015-10       Impact factor: 4.074

3.  Importance of reciprocal balance of T cell immunity in Mycobacterium abscessus complex lung disease.

Authors:  Su-Young Kim; Won-Jung Koh; Yee Hyung Kim; Byeong-Ho Jeong; Hye Yun Park; Kyeongman Jeon; Jong-Seok Kim; Sang-Nae Cho; Sung Jae Shin
Journal:  PLoS One       Date:  2014-10-08       Impact factor: 3.240

4.  Biomarkers for diagnosis of childhood tuberculosis: A systematic review.

Authors:  Toyin Omotayo Togun; Emily MacLean; Beate Kampmann; Madhukar Pai
Journal:  PLoS One       Date:  2018-09-13       Impact factor: 3.240

5.  Combined IFN-γ and IL-2 release assay for detect active pulmonary tuberculosis: a prospective multicentre diagnostic study in China.

Authors:  Yaoju Tan; Yunhong Tan; Junlian Li; Pengnan Hu; Ping Guan; Haobin Kuang; Qide Liang; Yanyan Yu; Zhongnan Chen; Quan Wang; Zhenping Yang; DiLiNaZi AiKeReMu; Yu Pang; Jianxiong Liu
Journal:  J Transl Med       Date:  2021-07-03       Impact factor: 5.531

6.  Cytokine and Antibody Based Diagnostic Algorithms for Sputum Culture-Positive Pulmonary Tuberculosis.

Authors:  Tao Chen; Jinfei Lin; Wei Wang; Joy Fleming; Liang Chen; Yunxia Wang; Haicheng Li; Huixin Guo; Jie Zhou; Xunxun Chen; Yuhui Chen; Qinghua Liao; Yang Shu; Yaoju Tan; Meiling Yu; Guozhou Li; Lin Zhou; Qiu Zhong; Lijun Bi; Lina Guo; Meigui Zhao
Journal:  PLoS One       Date:  2015-12-16       Impact factor: 3.240

7.  Identification of plasma biomarkers for discrimination between tuberculosis infection/disease and pulmonary non tuberculosis disease.

Authors:  Marco Pio La Manna; Valentina Orlando; Paolo Li Donni; Guido Sireci; Paola Di Carlo; Antonio Cascio; Francesco Dieli; Nadia Caccamo
Journal:  PLoS One       Date:  2018-03-15       Impact factor: 3.240

8.  Infant TB Infection Prevention Study (iTIPS): a randomised trial protocol evaluating isoniazid to prevent M. tuberculosis infection in HIV-exposed uninfected children.

Authors:  Sylvia M LaCourse; Barbra A Richardson; John Kinuthia; A J Warr; Elizabeth Maleche-Obimbo; Daniel Matemo; Lisa M Cranmer; Jaclyn N Escudero; Thomas R Hawn; Grace C John-Stewart
Journal:  BMJ Open       Date:  2020-01-21       Impact factor: 2.692

9.  Plasma chemokines are biomarkers of disease severity, higher bacterial burden and delayed sputum culture conversion in pulmonary tuberculosis.

Authors:  Nathella P Kumar; Kadar Moideen; Arul Nancy; Vijay Viswanathan; Basavaradhya S Shruthi; Shanmugam Sivakumar; Mohan Natarajan; Hardy Kornfeld; Subash Babu
Journal:  Sci Rep       Date:  2019-12-03       Impact factor: 4.379

10.  GrpE Immunization Protects Against Ureaplasma urealyticum Infection in BALB/C Mice.

Authors:  Yanhong Tang; Fangyi Guo; Aihua Lei; Jing Xiang; Pengqin Liu; Wenyou Ten; Guozhi Dai; Ranhui Li
Journal:  Front Immunol       Date:  2020-07-31       Impact factor: 7.561

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.